{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:44:34Z","timestamp":1780454674348,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-022-03159-9","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T11:02:42Z","timestamp":1660388562000},"page":"13-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intensive vs. conventional blood pressure goals in older patients with type 2 diabetes: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"78","author":[{"given":"Rene","family":"Rodriguez-Gutierrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Flores-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Raygoza-Cortez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Garcia-Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Mari\u00f1o-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiram H.","family":"Plata-Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"S\u00e1enz-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz A.","family":"Ramirez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Rojo-Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridoula","family":"Maraka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naikky V.","family":"Singh-Ospina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan P.","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose G.","family":"Gonzalez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,13]]},"reference":[{"key":"3159_CR1","doi-asserted-by":"crossref","unstructured":"R. Klein, B.E.K. Klein, K.E. Lee, K.J. Cruickshanks, S.E. Moss. The incidence of hypertension in insulin-dependent diabetes. Arch. Intern. Med. 622\u2013627 (1996)","DOI":"10.1001\/archinte.156.6.622"},{"key":"3159_CR2","doi-asserted-by":"crossref","unstructured":"B. Waeber, F. Feihl, L. Ruilope. Diabetes and hypertension. Blood Pressure 311\u2013321 (2001)","DOI":"10.1080\/080370501753400610"},{"key":"3159_CR3","doi-asserted-by":"crossref","unstructured":"R.M. Lago, P.P. Singh, R.W. Nesto. Diabetes and hypertension. Nat. Clin. Pract. Endocrinol. Metab. 3(10), 667 (2007)","DOI":"10.1038\/ncpendmet0638"},{"key":"3159_CR4","doi-asserted-by":"crossref","unstructured":"E. Ferrannini, W. Cushman. Diabetes and hypertension: the bad companions. Lancet 601\u2013610 (2012)","DOI":"10.1016\/S0140-6736(12)60987-8"},{"key":"3159_CR5","doi-asserted-by":"crossref","unstructured":"K. Mills, A.Stefanescu, J. He. The global epidemiology of hypertension. Nat. Rev. Nephrol. 223\u2013237 (2020)","DOI":"10.1038\/s41581-019-0244-2"},{"key":"3159_CR6","doi-asserted-by":"crossref","unstructured":"I. de Boer, S. Bangalore, A. Benetos, A. Davis, E. Michos, P. Muntner, et al. Diabetes and hypertension: a position statement by the American Diabetes Association. Diabetes Care 1273\u20131284 (2017)","DOI":"10.2337\/dci17-0026"},{"key":"3159_CR7","first-page":"e127","volume":"2018","author":"PK Whelton","year":"2017","unstructured":"P.K. Whelton, R.M. Carey, W.S. Aronow, D.E. Casey, K.J. Collins, C. Dennison Himmelfarb et al. ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2018, e127\u2013e248 (2017)","journal-title":"J. Am. Coll. Cardiol."},{"key":"3159_CR8","unstructured":"2018 ESC\/ESHGuidelines for themanagement of arterial hypertension, (2018)"},{"key":"3159_CR9","doi-asserted-by":"crossref","unstructured":"T. Unger, C. Borghi, F. Charchar, N.A. Khan, N.R. Poulter, D. Prabhakaran, et al. International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension (2020)","DOI":"10.1161\/HYPERTENSIONAHA.120.15026"},{"issue":"Supplement 1","key":"3159_CR10","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.2337\/dc21-s010","volume":"44","author":"AD Association","year":"2021","unstructured":"A.D. Association, Cardiovascular disease and risk management: standards of medical care in diabetes\u20142021. Diabetes Care 44(Supplement 1), S125\u2013S50 (2021). https:\/\/doi.org\/10.2337\/dc21-s010","journal-title":"Diabetes Care"},{"key":"3159_CR11","doi-asserted-by":"crossref","unstructured":"k. McBrien, D. Rabi, N. Campbell, L. Barnieh, F. Clement, B. Hemmelgarn, et al. Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: systematic review and meta-analysis. Arch. Intern. Med. 1296\u20131303 (2012)","DOI":"10.1001\/archinternmed.2012.3147"},{"key":"3159_CR12","doi-asserted-by":"crossref","unstructured":"C.A. Emdin, K. Rahimi, B. Neal, T. Callender, V. Perkovic, A. Patel. Blood pressure lowering in type 2 diabetes a systematic review and meta-analysis. JAMA 603\u2013615 (2015)","DOI":"10.1001\/jama.2014.18574"},{"key":"3159_CR13","doi-asserted-by":"crossref","unstructured":"M. Brunstr\u00f6m, B. Carlberg. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ i717 (2016)","DOI":"10.1136\/bmj.i717"},{"key":"3159_CR14","doi-asserted-by":"crossref","unstructured":"X. Xie, E. Atkins, J. Lv, A. Bennett, B. Neal, T. Ninomiya, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet 435\u2013443 (2016)","DOI":"10.1016\/S0140-6736(15)00805-3"},{"key":"3159_CR15","doi-asserted-by":"publisher","unstructured":"A.P. Herrera, S.A. Snipes, D.W. King, I. Torres-Vigil, D.S. Goldberg, A.D. Weinberg. Disparate Inclusion of Older Adults in Clinical Trials: Priorities and Opportunities for Policy and Practice Change. American Journal of Public Health 100, S105\u2013S112 (2010). https:\/\/doi.org\/10.2105\/ajph.2009.162982","DOI":"10.2105\/ajph.2009.162982"},{"key":"3159_CR16","unstructured":"M. Steverson. Ageing and Health World Health Organization (2021). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ageing-and-health"},{"key":"3159_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, 71 (2021). https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"3159_CR18","doi-asserted-by":"crossref","unstructured":"T. McGinn, P. Wyer, T. Newman, S. Keitz, R. Leipzig, For G. Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). Can. Med. Assoc. J. 1369\u20131373 (2004)","DOI":"10.1503\/cmaj.1031981"},{"key":"3159_CR19","doi-asserted-by":"crossref","unstructured":"Sterne J, Savovi\u0107 J, Page M, Elbers R, Blencowe N, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed) (2019)","DOI":"10.1136\/bmj.l4898"},{"key":"3159_CR20","doi-asserted-by":"crossref","unstructured":"H. Balshem, M. Helfand, H. Sch\u00fcnemann, A. Oxman, R. Kunz, J. Brozek, et al. GRADE guidelines: 3. Rating the quality of evidence. J. Clin. Epidemiol. 401\u2013406 (2011)","DOI":"10.1016\/j.jclinepi.2010.07.015"},{"key":"3159_CR21","doi-asserted-by":"crossref","unstructured":"V. Papademetriou, M. Zaheer, M. Doumas, L. Lovato, W.B. Applegate, C. Tsioufis, et al. Cardiovascular outcomes in action to control cardiovascular risk in diabetes: impact of blood pressure level and presence of kidney disease. Am. J. Nephrol. 271\u2013280 (2016)","DOI":"10.1159\/000446122"},{"key":"3159_CR22","unstructured":"K. Ueki, T. Sasako, Y. Okazaki, M. Kato, S. Okahata, H. Katsuyama, et al. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 951\u2013964 (2017)"},{"key":"3159_CR23","doi-asserted-by":"crossref","unstructured":"R. Fogari, P. Preti, A. Zoppi, A. Rinaldi, L. Corradi, C. Pasotti, et al. Effects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients. Am. J. Hypertens. 1042-1049 (2002)","DOI":"10.1016\/S0895-7061(02)03017-0"},{"key":"3159_CR24","doi-asserted-by":"publisher","unstructured":"Group TAS. Effects of intensive blood-pressure control in type 2 diabetes mellitus. Massachusetts Medical Society 1575-1585 (2010). https:\/\/doi.org\/10.1056\/NEJMoa1001286","DOI":"10.1056\/NEJMoa1001286"},{"key":"3159_CR25","doi-asserted-by":"crossref","unstructured":"L. Hansson, A. Zanchetti, S. Carruthers, B. Dahl\u00f6f, D. Elmfeldt, S. Julius, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1755\u20131762 (1998)","DOI":"10.1016\/S0140-6736(98)04311-6"},{"key":"3159_CR26","doi-asserted-by":"crossref","unstructured":"Z. Liu, Z. Zhou, G. Huang, Y. Xiao, Z. Li, C. Liu, et al. Long-term effects intensive medical therapy on the development and progression of subclinical atherosclerosis and the metabolic syndrome in Chinese patients with type 2 diabetes mellitus. Medicine (2016)","DOI":"10.1097\/MD.0000000000005201"},{"key":"3159_CR27","doi-asserted-by":"crossref","unstructured":"R.R. Holman, S.K. Paul, M.A. Bethel, H.A.W. Neil, D.R. Matthews. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N. Engl. J. Med. 1565\u20131576 (2008)","DOI":"10.1056\/NEJMoa0806359"},{"key":"3159_CR28","doi-asserted-by":"crossref","unstructured":"R. Holman, S. Paul, M. Bethel, D. Matthews, H. Neil, 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 1577\u20131589 (2008)","DOI":"10.1056\/NEJMoa0806470"},{"key":"3159_CR29","doi-asserted-by":"crossref","unstructured":"R. Schrier, R. Estacio, P. Mehler, W. Hiatt. Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Nat. Clin. Pract. Nephrol. 428-438 (2007)","DOI":"10.1038\/ncpneph0559"},{"key":"3159_CR30","doi-asserted-by":"crossref","unstructured":"J. Williamson, M. Supiano, W. Applegate, D. Berlowitz, R. Campbell, G. Chertow, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years: a randomized clinical trial. JAMA 2673\u20132682 (2016)","DOI":"10.1001\/jama.2016.7050"},{"key":"3159_CR31","doi-asserted-by":"publisher","unstructured":"Group TSR. A randomized trial of intensive versus standard blood-pressure control. Massachusetts Medical Society 2103\u20132116 (2015). https:\/\/doi.org\/10.1056\/NEJMoa1511939","DOI":"10.1056\/NEJMoa1511939"},{"key":"3159_CR32","doi-asserted-by":"crossref","unstructured":"I. de Boer, G. Bakris, C. Cannon, Individualizing blood pressure targets for people with diabetes and hypertension: comparing the ADA and the ACC\/AHA recommendations. JAMA 1319-1320 (2018)","DOI":"10.1001\/jama.2018.0642"},{"key":"3159_CR33","doi-asserted-by":"crossref","unstructured":"Y. Takami, K. Yamamoto, H. Arima, A. Sakima. Target blood pressure level for the treatment of elderly hypertensive patients: a systematic review and meta-analysis of randomized trials. Hypertens Res. 660-668 (2019)","DOI":"10.1038\/s41440-019-0227-5"},{"key":"3159_CR34","doi-asserted-by":"crossref","unstructured":"J.A. Arguedas, V. Leiva, J.M. Wright, Blood pressure targets for hypertension in people with diabetes mellitus. Cochrane Database Syst. Rev. (2013)","DOI":"10.1002\/14651858.CD008277.pub2"},{"key":"3159_CR35","doi-asserted-by":"crossref","unstructured":"S. Greenfield, J. Billimek, F. Pellegrini, M. Franciosi, G. De Berardis, A. Nicolucci, et al. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann Intern. Med. 854 (2009)","DOI":"10.7326\/0003-4819-151-12-200912150-00005"},{"key":"3159_CR36","doi-asserted-by":"publisher","unstructured":"J.A. Arguedas, V. Leiva, J.M. Wright, Blood pressure targets in adults with hypertension. Cochrane Database Syst. Rev. 12 (2020). https:\/\/doi.org\/10.1002\/14651858.CD004349.pub3. PubMed PMID: CD004349","DOI":"10.1002\/14651858.CD004349.pub3"},{"key":"3159_CR37","doi-asserted-by":"publisher","unstructured":"A randomized trial of intensive versus standard blood-pressure control. N. Engl. J. Med. 373(22):2103\u20132116 (2015). https:\/\/doi.org\/10.1056\/nejmoa1511939","DOI":"10.1056\/nejmoa1511939"},{"issue":"2","key":"3159_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/10641963.2018.1462373","volume":"41","author":"G Chi","year":"2019","unstructured":"G. Chi, A. Jamil, U. Jamil, M.A. Balouch, J. Marszalek, F. Kahe et al. Effect of intensive versus standard blood pressure control on major adverse cardiac events and serious adverse events: a bivariate analysis of randomized controlled trials. Clin. Exp. Hypertens. 41(2), 160\u20137 (2019). https:\/\/doi.org\/10.1080\/10641963.2018.1462373","journal-title":"Clin. Exp. Hypertens."},{"key":"3159_CR39","doi-asserted-by":"crossref","unstructured":"R. Fogari, A. Zoppi, Effect of antihypertensive agents on quality of life in the elderly. Drugs Aging 377\u2013393 (2004)","DOI":"10.2165\/00002512-200421060-00003"},{"key":"3159_CR40","doi-asserted-by":"crossref","unstructured":"A. Benetos, C. Labat, P. Rossignol, R. Fay, Y. Rolland, F. Valbusa, et al. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE study. JAMA Intern. Med. 989\u2013995 (2015)","DOI":"10.1001\/jamainternmed.2014.8012"},{"key":"3159_CR41","doi-asserted-by":"publisher","unstructured":"J. Ulley, D. Harrop, A. Ali, S. Alton, S. Fowler Davis, Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review. BMC Geriatr. 19(1):15 (2019). https:\/\/doi.org\/10.1186\/s12877-019-1031-4. PubMed PMID: 30658576; PubMed Central PMCID: PMC6339421","DOI":"10.1186\/s12877-019-1031-4"},{"key":"3159_CR42","doi-asserted-by":"crossref","unstructured":"A. Cai, D.A. Calhoun, Antihypertensive medications and falls in the elderly. Am. J. Hypertens. 281\u2013283 (2018)","DOI":"10.1093\/ajh\/hpx203"},{"key":"3159_CR43","doi-asserted-by":"crossref","unstructured":"S. Ross, K. Akhras, S. Zhang, M. Rozinsky, L. Nalysnyk, Discontinuation of antihypertensive drugs due to adverse events: a systematic review and meta-analysis. Pharmacotherapy 940\u2013953 (2001)","DOI":"10.1592\/phco.21.11.940.34520"},{"key":"3159_CR44","doi-asserted-by":"publisher","unstructured":"B. Kanapuru, H. Singh, V. Kwitkowski, G. Blumenthal, A.T. Farrell, R. Pazdur, Older adults in hematologic malignancy trials: representation, barriers to participation and strategies for addressing underrepresentation. Blood Rev. 43:100670 (2020). https:\/\/doi.org\/10.1016\/j.blre.2020.100670. PubMed PMID: 32241586","DOI":"10.1016\/j.blre.2020.100670"},{"key":"3159_CR45","doi-asserted-by":"publisher","unstructured":"A.A. Mangoni, P.A. Jansen, S.H. Jackson, Under-representation of older adults in pharmacokinetic and pharmacodynamic studies: a solvable problem? Expert Rev. Clin. Pharmacol. 6(1):35\u201339 (2013). https:\/\/doi.org\/10.1586\/ecp.12.75. PubMed PMID: 23272791","DOI":"10.1586\/ecp.12.75"},{"key":"3159_CR46","doi-asserted-by":"publisher","unstructured":"M.J. Schaap, M.E.C. van Winden, M.M.B. Seyger, E. de Jong, S.F.K. Lubeek, Representation of older adults in randomized controlled trials on systemic treatment in plaque psoriasis: a systematic review. J. Am. Acad. Dermatol. 83(2):412\u2013424 (2020). https:\/\/doi.org\/10.1016\/j.jaad.2019.07.079. PubMed PMID: 31369769","DOI":"10.1016\/j.jaad.2019.07.079"},{"issue":"1","key":"3159_CR47","doi-asserted-by":"publisher","first-page":"e000656","DOI":"10.1136\/bmjdrc-2019-000656","volume":"7","author":"AT Kelley","year":"2019","unstructured":"A.T. Kelley, K. Mizokami-Stout, M.J. O\u2019Brien, M.E. Bowen, J. Sussman, Hispanic representation in diabetes cardiovascular outcomes trials. BMJ Open Diabetes Res. Care 7(1), e000656 (2019). https:\/\/doi.org\/10.1136\/bmjdrc-2019-000656. Epub 2019\/06\/28PubMed PMID: 31245007; PubMed Central PMCID: PMC6557465","journal-title":"BMJ Open Diabetes Res. Care"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03159-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03159-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03159-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T12:20:45Z","timestamp":1663158045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03159-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,13]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["3159"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03159-9","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,13]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Patients or the public were not involved in the design, conduct, reporting or dissemination plans of our research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient involvement"}},{"value":"The manuscript\u2019s guarantors affirm that the manuscript is an honest, accurate and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned and registered have been explained. This manuscript has not been deposited as a preprint.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency"}}]}}